your badges 52W Range $0–$3 1% of range Analyst Rating BUY 7 analysts Price Target $12 +2464% upside P/E -4.5 ROE · Net Profit Margin ·

ESLA Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range

03
Price $0.47
P/E -4.5
52W Range $0–$3

ESLA Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view

04
range
bars

Bar granularity adapts to the selected period — hover the chart to see open/high/low/close for a bar.

10-Year Performance Revenue, net income, margins and EPS trends

06
Valuation & Ratios 07–12

Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?

Metric 5Y trend ESLA 5Y avg Peer Median Verdict
P/E -4.5 · · ·

Peer median is calculated on a standardized basis per metric and may not always match the TTM/MRQ basis shown for this stock.

value · ≈ 5Y avg · industry median · verdict relative to median

Earnings History EPS actual vs estimate, surprise %, beat rate, next earnings date

14
Avg Surprise -28.9%
Next Report Nov 10, 2026
PeriodReportEPS ActualEPS EstSurprise
Dec. 31, 2025 $-0.35 $-0.18 -90.6%
Sept. 30, 2025 $-0.13 $-0.19 32.9%
June 30, 2025 $-0.35 $-0.18 -90.6%
March 31, 2025 $-0.13 $-0.19 32.9%

Full Fundamentals All metrics by year — income statement, balance sheet, cash flow

15
Balance Sheet 11
Metric Trend 2025
Prepaid Expense $292.7K
Current Assets $2M
Total Assets $3M
Current Liabilities $14M
Total Liabilities $14M
Common Stock $3.8K
Paid-in Capital $27M
Retained Earnings $-37M
Treasury Stock $598.4K
Stockholders' Equity $-10M
Liabilities + Equity $3M
Per Share 1
Metric Trend 2025
EPS (TTM) $-0.35
Valuation (TTM) 3
Metric Trend 2025
Net Income TTM $-13M
P/E -4.5
Earnings Yield -22.4%

Most recent period on the left · null values shown as ·

Financial Statements Income statement, balance sheet, cash flow — annual, last 5 years

16
No data for this statement

Not enough fundamentals data to build this statement yet.

Institutional owners (13F) 18 filers · $5.7M total · As of June 30, 2026

17

Institutions that report holding this stock in their quarterly SEC Form 13F. Long positions only; a single filer may appear twice for separate option legs. Large offsetting put/call legs typically reflect market-making or hedged inventory, not directional conviction.

Holders 18
Value held $5.7M
New positions 2
Exited positions 3
Institutional activity — Q2 2026 vs prior quarter
New positions Exited positions Increased Decreased Net shares change
2 (-6 vs prior Q) 3 (-3 vs prior Q) 4 (+1 vs prior Q) 5 (+3 vs prior Q) -385K

Compared to Q1 2026. SEC Form 13F filings are due within 45 days of quarter-end plus a short buffer for late filers — quarters still inside that window are skipped in favor of the most recent fully-reported pair.

Institution Value Shares % of tracked 13F Type
ARMISTICE CAPITAL, LLC $4,134,229 3,975,220 71.98% Shares
VANGUARD GROUP INC $700,074 448,765 12.19% Shares
VANGUARD CAPITAL MANAGEMENT LLC $433,526 416,852 7.55% Shares
GEODE CAPITAL MANAGEMENT, LLC $146,973 141,321 2.56% Shares
VANGUARD FIDUCIARY TRUST CO $67,518 64,921 1.18% Shares
BlackRock, Inc. $54,114 52,033 0.94% Shares
ATW SPAC MANAGEMENT LLC $46,000 40,000 0.80% Shares
STATE STREET CORP $44,982 43,252 0.78% Shares
RENAISSANCE TECHNOLOGIES LLC $40,664 39,100 0.71% Shares
NORTHERN TRUST CORP $36,255 34,861 0.63% Shares
US BANCORP \DE\ $20,800 20,000 0.36% Shares
Maso Capital Partners Ltd $11,500 10,000 0.20% Shares
Tower Research Capital LLC (TRC) $3,440 3,308 0.06% Shares
UBS Group AG $1,790 1,721 0.03% Shares
TORONTO DOMINION BANK $1,133 1,089 0.02% Shares
WOLVERINE ASSET MANAGEMENT LLC $487 468 0.01% Shares
BARCLAYS PLC $131 126 0.00% Shares
Caitong International Asset Management Co., Ltd $2 2 0.00% Shares

Activists & 5%+ owners 1 position

18

Investors who filed SEC Schedule 13D — beneficial ownership above 5% with an intent to influence the issuer (activist stakes, board campaigns, M&A). Each row shows the most recent known state of that filer's position.

Filer Filed Stake Status Purpose Filing
Eureka Therapeutics, Inc. (2) Oct. 30, 2023 · Initial filing Passive investment SEC

Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.

Company insiders 3 insiders · 3 officers · 2 directors

19
Insider Role Last activity Shares owned Buys 12m Sells 12m Net 12m
Cheng Liu Chief Executive Officer Oct. 30, 2024 A · 0 0 $0
Jianwei Li Co-Chief Executive Officer March 4, 2022 P 1,253,730 0 0 $0
Jiandong Xu Chief Financial Officer Oct. 7, 2025 P 265,488 3 0 $2,594

Insiders from SEC Form 3/4/5 filings; net = open-market P/S only

ETF ownership Held by 3 ETFs

20

Weight reflects direct equity holdings (N-PORT) only; leveraged or derivative-based funds may hold additional swap exposure not shown.

Fund Weight Units As of Source
IWC · iShares Trust 0.00% 49,333 SH Sept. 11, 2026 Daily
VXF · VANGUARD INDEX FUNDS 0.00% 148,247 SH Aug. 19, 2026 Daily
VTI · VANGUARD INDEX FUNDS 0.00% 268,605 SH Aug. 19, 2026 Daily

ESLA Analyst Consensus Bullish and bearish analyst opinions, 12-month price target, upside

21
rating · 7 analysts BUY
Median target $12.00 +2464.1%
2 28.6% Strong Buy
4 57.1% Buy
1 14.3% Hold
0 0.0% Sell
0 0.0% Strong Sell

12-Month Price Target

1 analysts · 2026-09-29

Mean target $12.00 +2464.1%

Low$12.00 Mean$12.00 High$12.00

Peer comparison (GICS sub-industry) Key metrics vs sector peers

22

FY basis, prices as of each company's last fiscal year-end close.

Ticker Market Cap P/E Rev YoY Net Margin ROE Gross Margin
ESLA · -4.5 · · · ·
TCRX · -1.0 266.7% -1256.8% -86.6% ·
JSPR · -0.5 · · · ·
ACTU $142M -5.8 · · -843.5% ·
NEUP $24M -1.4 -92.5% -1145.7% -49.5% ·
DYAI · -4.1 -11.6% · · ·
SHPH $4M -0.3 0.00% · -400.1% ·

My Metrics Your personal watchlist — selected rows from Full Fundamentals

26

Pick the metrics that matter to you — click the + next to any row in Full Fundamentals above.

Your selection is saved and follows you across all tickers.

Source: SEC 10-Q filed May 18, 2026